HK1242920A1 - 14-元酮内酯及其制备和使用方法 - Google Patents

14-元酮内酯及其制备和使用方法 Download PDF

Info

Publication number
HK1242920A1
HK1242920A1 HK18102636.6A HK18102636A HK1242920A1 HK 1242920 A1 HK1242920 A1 HK 1242920A1 HK 18102636 A HK18102636 A HK 18102636A HK 1242920 A1 HK1242920 A1 HK 1242920A1
Authority
HK
Hong Kong
Prior art keywords
methods
ketolides
preparation
membered
eastern
Prior art date
Application number
HK18102636.6A
Other languages
English (en)
Chinese (zh)
Inventor
A.G.迈尔斯
A．G．邁爾斯
I.B.赛普勒
Z.张
I．B．賽普勒
Z．張
Original Assignee
哈佛大学的校长及成员们
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 哈佛大学的校长及成员们 filed Critical 哈佛大学的校长及成员们
Publication of HK1242920A1 publication Critical patent/HK1242920A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HK18102636.6A 2014-10-08 2015-10-08 14-元酮内酯及其制备和使用方法 HK1242920A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462061571P 2014-10-08 2014-10-08
US62/061,571 2014-10-08
PCT/US2015/054700 WO2016057798A1 (en) 2014-10-08 2015-10-08 14-membered ketolides and methods of their preparation and use

Publications (1)

Publication Number Publication Date
HK1242920A1 true HK1242920A1 (zh) 2018-07-06

Family

ID=55653777

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18102636.6A HK1242920A1 (zh) 2014-10-08 2015-10-08 14-元酮内酯及其制备和使用方法

Country Status (7)

Country Link
US (3) US10633407B2 (enExample)
EP (1) EP3211997A4 (enExample)
JP (1) JP2017531663A (enExample)
CN (1) CN106998685A (enExample)
CA (1) CA2963815A1 (enExample)
HK (1) HK1242920A1 (enExample)
WO (1) WO2016057798A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX377459B (es) 2013-04-04 2025-03-10 Harvard College Macrolidos y metodos para su preparacion y uso.
WO2016057798A1 (en) 2014-10-08 2016-04-14 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
WO2016154591A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
WO2018201076A2 (en) 2017-04-28 2018-11-01 Macrolide Pharmaceuticals Inc. Macrolides with modified desosamine sugars and uses thereof
BR112021009607A2 (pt) * 2018-11-19 2021-08-10 Zikani Therapeutics, Inc. macrolídeos de 13 membros substituídos c10-cíclicos e usos dos mesmos
KR20210133950A (ko) 2018-11-19 2021-11-08 지카니 테라퓨틱스, 인크. C10-알킬렌 치환된 13-원 매크롤라이드 및 이의 용도
IL303173A (en) * 2023-05-23 2024-12-01 Yeda Res & Dev Active macrolide antibiotic compounds against pathogens
WO2025228440A1 (zh) * 2024-04-30 2025-11-06 苏州信诺维医药科技股份有限公司 大环内酯类化合物、其制备方法及其用途

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA859575B (en) 1984-12-21 1986-08-27 Hoffmann La Roche Oxetanones
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
JP3652394B2 (ja) 1995-01-27 2005-05-25 高砂香料工業株式会社 Ｎ−置換−７−アミノ−５−ヒドロキシ−３−オキソヘプタン酸誘導体およびその製造法
HN1998000074A (es) 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
WO1999000125A1 (en) 1997-06-27 1999-01-07 Merck & Co., Inc. 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
HN1998000159A (es) 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
GB9814006D0 (en) * 1998-06-29 1998-08-26 Biotica Tech Ltd Polyketides and their synthesis
FR2785612A1 (fr) 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6262030B1 (en) 1998-11-03 2001-07-17 Pfizer Inc. Erythromycin derivatives
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6939861B2 (en) * 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
CN1373767A (zh) * 1999-04-16 2002-10-09 奥索-麦克尼尔药品公司 酮式大环内酯抗菌剂
HRP990116B1 (en) 1999-04-20 2007-10-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
HK1045523A1 (zh) * 1999-05-24 2002-11-29 辉瑞产品公司 13-甲基红霉素衍生物
AU6316400A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
BR0009101A (pt) 1999-08-24 2002-02-05 Abbott Lab 9a-azalidas com atividade antibacteriana
AU779748C (en) 2000-01-27 2005-12-08 Zoetis Services Llc Azalide antibiotic compositions
JP4596591B2 (ja) 2000-03-09 2010-12-08 塩野義製薬株式会社 ８ａ−オキサホモエリスロマイシン誘導体、製造方法、合成中間体および医薬組成物
US6440942B1 (en) * 2000-12-22 2002-08-27 Enanta Pharmaceuticals, Inc. 14-membered macrolides derived from leucomycins
NZ533282A (en) * 2001-12-05 2006-09-29 Ortho Mcneil Pharm Inc 6-O-Acyl ketolide derivatives of erythromycine useful as antibacterials
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
BR0316746A (pt) * 2002-11-29 2005-10-18 Mercian Corp Método de produção do composto macrolida 11107d, linhagem streptomyces sp.ab-1704 (ferm bp-8551), linhagem mortierella sp. f1529 (ferm bp-8547) ou linhagem f-1530 (ferm bp-8548), e linhagem ab-1896 (ferm bp-8550)
WO2004065346A1 (ja) 2003-01-21 2004-08-05 Sumitomo Chemical Company, Limited （－）－テトラヒドロリプスタチンおよびその中間体の製造方法
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
HRP20030381B1 (en) 2003-05-14 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
BRPI0513903A (pt) * 2004-07-28 2008-05-20 Ranbaxy Lab Ltd derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos
US7767797B1 (en) 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
US20060096158A1 (en) 2004-11-08 2006-05-11 Robinson J M Lactones as new oxygenate fuel additives, fuels based thereon and methods for using same
EP1841775A2 (en) * 2005-01-12 2007-10-10 Alpharma APS Erythromycin derivatives as antibacterial agents
CN101103039A (zh) 2005-01-12 2008-01-09 阿尔法马股份公司 作为抗菌剂的红霉素衍生物
CN101142225B (zh) 2005-01-13 2011-09-07 葛兰素集团有限公司 具有抗炎活性的大环内酯
EP1879903A1 (en) 2005-05-10 2008-01-23 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Ether linked macrolides useful for the treatment of microbial infections
RU2008106915A (ru) 2005-07-26 2009-09-10 Меркле Гмбх (De) Макролидные конъюгаты пирролиновых и индолизиновых соединений
CN101282967B (zh) 2005-10-13 2011-01-26 卫材R&D管理有限公司 普拉二烯内酯b和普拉二烯内酯d的全合成
US8097708B2 (en) 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
EP2056844A4 (en) * 2006-08-24 2010-11-24 Wockhardt Research Center NEW MACROLIDS AND KETOLIDS WITH ANTIMICROBIAL EFFECT
JP4468487B1 (ja) 2007-03-13 2010-05-26 ファイザー・プロダクツ・インク エリスロマイシンをベースとするマクロライド
US9453042B2 (en) 2007-10-25 2016-09-27 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US20090209547A1 (en) 2008-02-15 2009-08-20 In Jong Kim C-8 halogenated macrolides
KR100980379B1 (ko) 2008-04-02 2010-09-06 주식회사 파마코스텍 광학활성을 갖는 5-히드록시-3-옥소헵타노에이트 유도체의제조방법
WO2010015703A2 (en) 2008-08-07 2010-02-11 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Novel 6-o-substituted 15-membered 8a- and 9a-lactams
HRP20160222T1 (hr) 2008-10-24 2016-04-08 Cempra Pharmaceuticals, Inc. Biozaštite uporabom makrolida koji sadrže triazol
US8865662B2 (en) 2009-08-13 2014-10-21 Basilea Pharmaceutica Ag Macrolides and their use
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
ES2637072T3 (es) 2010-03-10 2017-10-10 Cempra Pharmaceuticals, Inc. Formulación parenteral de antibióticos macrólidos
JP5711352B2 (ja) 2010-03-22 2015-04-30 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライドの結晶形、およびその使用
WO2011131749A1 (en) * 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
WO2012001089A1 (en) 2010-07-01 2012-01-05 Novartis Ag Antibiotic compositions
WO2012016186A1 (en) * 2010-07-29 2012-02-02 President And Fellows Of Harvard College Macrocyclic kinase inhibitors and uses thereof
US8796474B1 (en) * 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
WO2012051126A2 (en) 2010-10-10 2012-04-19 Synovo Gmbh Anti-inflammatory macrolides
CN103619863B (zh) * 2011-03-22 2016-03-16 沃克哈特有限公司 酮内酯化合物的制备方法
CN102690297A (zh) 2011-03-22 2012-09-26 连云港海康生物科技有限公司 一种壳寡糖季铵盐及其合成方法
JP6023192B2 (ja) * 2011-07-01 2016-11-09 プレジデント アンド フェローズ オブ ハーバード カレッジ 大環状インスリン分解酵素（ｉｄｅ）阻害剤およびその使用
IN2014DN08939A (enExample) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
CA2905975A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
EP2968384A4 (en) 2013-03-15 2017-02-15 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
MX377459B (es) 2013-04-04 2025-03-10 Harvard College Macrolidos y metodos para su preparacion y uso.
WO2016057798A1 (en) 2014-10-08 2016-04-14 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
WO2016154591A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
HK1250719A1 (zh) 2015-03-25 2019-01-11 President And Fellows Of Harvard College 脱氧糖胺的合成

Also Published As

Publication number Publication date
EP3211997A1 (en) 2017-09-06
US20200361980A1 (en) 2020-11-19
WO2016057798A1 (en) 2016-04-14
EP3211997A4 (en) 2018-10-24
US11466046B2 (en) 2022-10-11
CN106998685A (zh) 2017-08-01
US20230109357A1 (en) 2023-04-06
US20170305953A1 (en) 2017-10-26
US10633407B2 (en) 2020-04-28
JP2017531663A (ja) 2017-10-26
CA2963815A1 (en) 2016-04-14

Similar Documents

Publication Publication Date Title
HK1242920A1 (zh) 14-元酮内酯及其制备和使用方法
ZA202311311B (en) Anti-bcma heavy chain-only antibodies
ZA201903985B (en) Anti-bcma heavy chain-only antibodies
NZ731789A (en) Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof
MX2024014319A (es) Anticuerpos anti-bcma unicamente de cadena pesada
WO2015164392A3 (en) Novel antii-rnf43 antibodies and methods of use
WO2014165792A3 (en) Macrolides and methods of their preparation and use
ZA201806576B (en) Antibodies, pharmaceutical compositions and methods
WO2016094837A3 (en) Anti-c10orf54 antibodies and uses thereof
MX2022001105A (es) Anticuerpos anti tigit.
WO2017031458A3 (en) Anti-dll3 antibody drug conjugates and methods of use
WO2017030823A3 (en) Anti-tigit antibodies
MX2021010418A (es) Composiciones que comprenden una caseína y métodos para producir las mismas.
MX421186B (es) Constructos de anticuerpos.
HK1218621A1 (zh) 用於治疗慢性炎症和炎性疾病的组合物及方法
TW201613893A (en) Process for the preparation of 3-(3-chloro-1H-pyrazol-1-yl)pyridine
EP3144292A4 (en) 2,3,4,6-tetra-substituted benzene-1,5-diamine derivatives, preparation method therefor and medicinal use thereof
EP3158073B8 (en) Compositions and methods for making (s)-norcoclaurine and (s)-norlaudanosoline, and synthesis intermediates thereof
EP3225215A4 (en) Lumen stent and preform thereof, and methods for preparing lumen stent and preform thereof
EP3229793A4 (en) Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease
MX2019014475A (es) Formulaciones de lixivaptan para el tratamiento de enfermedades poliquisticas.
PH12017501545A1 (en) Proflavor delivery powders
HK1234311A1 (en) Novel anti-rnf43 antibodies and methods of use
HK1238261A1 (en) Novel anti-mfi2 antibodies and methods of use